• China Shineway set a revised board lineup effective Oct. 1, 2026.
• Executive directors: Li Zhenjiang, Li Huimin.
• Independent non-executive directors: Liu Shun Fai, Yew Yat On, Wang Guihua.
• Non-executive director: Zhou Wencheng.
• Committee chairs: Liu Shun Fai (audit, CSR/sustainability); Li Zhenjiang (nomination); Wang Guihua (remuneration).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Shineway Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260929-12349932), on September 29, 2026, and is solely responsible for the information contained therein.